Processing

Please wait...

Settings

Settings

Goto Application

1. WO2014102439 - METHOD FOR OBTAINING USEFUL DATA FOR PREDICTING THE RESPONSE TO THE TREATMENT OF HEPATITIS C

Publication Number WO/2014/102439
Publication Date 03.07.2014
International Application No. PCT/ES2013/070938
International Filing Date 30.12.2013
IPC
C12Q 1/68 2006.1
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
1Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
68involving nucleic acids
A61K 38/21 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17from animals; from humans
19Cytokines; Lymphokines; Interferons
21Interferons
CPC
A61K 31/7056
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
7042Compounds having saccharide radicals and heterocyclic rings
7052having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
7056containing five-membered rings with nitrogen as a ring hetero atom
A61K 38/21
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17from animals; from humans
19Cytokines; Lymphokines; Interferons
21Interferons ; [IFN]
C12Q 1/6883
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS
1Measuring or testing processes involving enzymes, nucleic acids or microorganisms
68involving nucleic acids
6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
6883for diseases caused by alterations of genetic material
C12Q 2600/106
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS
2600Oligonucleotides characterized by their use
106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
C12Q 2600/156
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS
2600Oligonucleotides characterized by their use
156Polymorphic or mutational markers
Applicants
  • UNIVERSIDAD DE CÓRDOBA [ES]/[ES]
  • SERVICIO ANDALUZA DE SALUD [ES]/[ES]
Inventors
  • PEÑA MARTÍNEZ, José
  • GONZÁLEZ FERNÁNDEZ, Rafael
  • RIVERO ROMÁN, Antonio
  • MANZANARES MARTÍN, Bárbara
  • RIVERO JUÁREZ, Antonio
  • CAMACHO ESPEJO, Ángela
  • DE LA TORRE CISNEROS, Julián
Priority Data
P20123206128.12.2012ES
Publication Language Spanish (es)
Filing Language Spanish (ES)
Designated States
Title
(EN) METHOD FOR OBTAINING USEFUL DATA FOR PREDICTING THE RESPONSE TO THE TREATMENT OF HEPATITIS C
(ES) MÉTODO DE OBTENCIÓN DE DATOS ÚTILES PARA PREDECIR LA RESPUESTA AL TRATAMIENTO DE LA HEPATITIS C
(FR) MÉTHODE D'OBTENTION DE DONNÉES UTILES POUR PRÉDIRE LA RÉPONSE AU TRAITEMENT DE L'HÉPATITE C
Abstract
(EN) The invention relates to the use of the KIR3DS1 gene for predicting or forecasting the response of an individual to the treatment of HCV with peg-IFN in addition to a guanosine analogue, preferably ribavirin (RBV). The invention also relates to a method, a kit and uses.
(ES) El uso del gen KIR3DS1para predecir o pronosticar la respuesta de un individuo al tratamiento del VHC con IFN-Peg más un análogo de guanosina, preferentemente ribavirina (RBV), método, kit y usos.
(FR) L'invention concerne l'utilisation du gène KIR3DS1 pour prédire ou pronostiquer la réponse d'un individu au traitement du VHC par interféron pégylé plus un analogue de guanosine, de préférence de la ribavirine (RBV), ainsi qu'une méthode, un nécessaire et leurs utilisations.
Related patent documents
Latest bibliographic data on file with the International Bureau